Neuroprotective effects of chronic hesperetin administration in mice

Archives of Pharmacal Research

Volumn 31, Issue 11, 2008, Pages 1457-1462

  Choi, Eun Jeong ^a   Ahn, Woong Shick ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Antioxidant; Apoptosis; Hesperetin; In vivo; Neuroprotective

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE; HESPERETIN; HESPERIDIN; NEUROPROTECTIVE AGENT; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL; ARTICLE; BRAIN LEVEL; DRUG EFFECT; FEMALE; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MOUSE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; BRAIN CHEMISTRY; CATALASE; FEMALE; GLUTATHIONE; HESPERIDIN; MICE; MICE, INBRED ICR; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PROTEIN CARBONYLATION; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 56749179749     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-2130-1     Document Type: Article

References (35)

1. J. D. Adams Jr. L. K. Klaidman I. N. Odunze H. C. Shen C. A. Miller 1991 Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E Mol. Chem. Neuropathol. 14 213 226
2. H. Aebi 1984 Catalase in vitro Methods Enzymol. 105 121 126
3. G. Aldini I. Dalle-Donne R. M. Facino A. Milzani M. Carini 2007 Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls Med. Res. Rev. 27 817 868
4. M. A. Ansari G. Joshi Q. Huang W. O. Opii H. M. Abdul R. Sultana D. A. Butterfield 2006 In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid beta-peptide and other oxidative stressors: relevance to Alzheimer's disease and other oxidative stress-related neurodegenerative disorders Free Radic. Biol. Med. 41 1694 1703
5. S. Bharath M. Hsu D. Kaur S. Rajagopalan J. K. Andersen 2002 Glutathione, iron and Parkinson's disease Biochem. Pharmacol. 64 1037 1048
6. E. Bonilla 2000 Huntington disease Invest. Clin. 41 117 141
7. I. Carlberg B. Mannervik 1985 Glutathione reductase Methods Enzymol. 113 484 490
8. J. Cho 2006 Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperetin Arch. Pharm. Res. 29 699 706
9. E. J. Choi G. D. Kim K. M. Chee G. H. Kim 2006 Effects of hesperetin on vessel structure formation in mouse embryonic stem (mES) cells Nutrition 22 947 951
10. E. J. Choi 2008 Antioxidative effects of hesperetin against 7,12-dimethylbenz(a)anthracene-induced oxidative stress in mice Life Sci. 82 1059 1064
11. Cooper, A. J. L., Glutathione in the brain: disorders of glutathione metabolism: The Molecular and Genetic Basis of Neurological Disease. Butterworth-Heinemann, Boston, 1997, pp. 1195-1230, (1997).
12. R. Cruz-Aguado L. F. Turner C. M. Diaz J. Pinero 2000 Nerve growth factor and striatal glutathione metabolism in a rat model of Huntington's disease Restor. Neurol. Neurosci. 17 217 221
13. E. Erdem R. Carlier A. B. Idir P. O. Masnou A. Moulonguet D. Adams D. Doyon 1993 Gadolinium-enhanced MRI in central nervous system Behçet's disease Neuroradiology 35 142 144
14. L. Flohé W. A. Günzler 1984 Assays of glutathione peroxidase Methods Enzymol. 105 114 121
15. 2-.), superoxide dismutases, and related matters J. Biol. Chem. 272 18515 18517
16. I. Fridovich 1995 Superoxide radical and superoxide dismutases Annu. Rev. Biochem. 64 97 112
17. A. Garg S. Garg L. J. Zaneveld A. K. Singla 2001 Chemistry and pharmacology of the Citrus bioflavonoid hesperidin Phytother. Res. 15 655 669
18. J. Hirrlinger J. B. Schulz R. Dringen 2002 Effects of dopamine on the glutathione metabolism of cultured astroglial cells: implications for Parkinson's disease J. Neurochem. 82 458 467
19. P. J. Hissin R. Hilf 1976 A fluorometric method for determination of oxidized and reduced glutathione in tissues Anal. Biochem. 74 214 226
20. Y. S. Ho J. L. Magnenat R. T. Bronson J. Cao M. Gargano M. Sugawara C. D. Funk 1997 Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia J. Biol. Chem. 272 16644 16651
21. Y. S. Ho L. Swenson U. Derewenda L. Serre Y. Wei Z. Dauter M. Hattori T. Adachi J. Aoki H. Arai K. Inoue Z. S. Derewenda 1997 Brain acetylhydrolase that inactivates platelet-activating factor is a G-protein-like trimer Nature 385 89 93
22. Hwang, S. L. and Yen, G. C., Neuroprotective effects of the citrus flavanones against H2O2-induced cytotoxicity in PC12 cells. J. Agric. Food Chem., 859-864 (2008).
23. A. Jaeger M. Wälti K. Neftel 1988 Side effects of flavonoids in medical practice Prog. Clin. Biol. Res. 280 379 394
24. J. Y. Kim K. J. Jung J. S. Choi H. Y. Chung 2004 Hesperetin: a potent antioxidant against peroxynitrite Free Radic. Res. 38 761 769
25. S. Marklund G. Marklund 1974 Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase Eur. J. Biochem. 47 469 474
26. P. I. Moreira S. L. Siedlak G. Aliev X. Zhu A. D. Cash M. A. Smith G. Perry 2005 Oxidative stress mechanisms and potential therapeutics in Alzheimer disease J. Neural Transm. 112 921 932
27. A. Nunomura P. I. Moreira H. G. Lee X. Zhu R. J. Castellani M. A. Smith G. Perry 2007 Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases CNS Neurol. Disord. Drug Targets 6 411 423
28. H. Ohkawa N. Ohishi K. Yagi 1979 Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 351 358
29. S. E. Pollard M. Whiteman J. P. Spencer 2006 Modulation of peroxynitrite-induced fibroblast injury by hesperetin: a role for intracellular scavenging and modulation of ERK signaling Biochem. Biophys. Res. Commun. 347 916 923
30. A. V. Rao B. Balachandran 2002 Role of oxidative stress and antioxidants in neurodegenerative diseases Nutr. Neurosci. 5 291 309
31. A. Z. Reznick L. Packer 1994 Oxidative damage to proteins: spectrophotometric method for carbonyl assay Methods Enzymol. 233 357 363
32. J. A. Ross C. M. Kasum 2002 Dietary flavonoids: bioavailability, metabolic effects, and safety Annu. Rev. Nutr. 22 19 34
33. J. Sian D. T. Dexter A. J. Lees S. Daniel Y. Agid F. Javoy-Agid P. Jenner C. D. Marsden 1994 Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia Ann. Neurol. 36 348 355
34. K. Suk 2005 Regulation of neuroinflammation by herbal medicine and its implications for neurodegenerative diseases. A focus on traditional medicines and flavonoids Neurosignals. 14 23 33
35. Y. Zhu P. M. Carvey Z. Ling 2006 Age-related changes in glutathione and glutathione-related enzymes in rat brain Brain Res. 1090 35 44